EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors

Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Jan 8, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a type of therapy called EMDR (Eye Movement Desensitization and Reprocessing) to see if it can help cancer survivors who are still experiencing nausea and vomiting due to their past chemotherapy treatments. The goal is to find out if this therapy can reduce these uncomfortable symptoms for those who have been dealing with them for more than two months after their cancer treatment.

To be part of the trial, you need to be 18 years or older and have a confirmed history of cancer, along with ongoing nausea or vomiting. However, you should not be currently receiving psychiatric treatment or have certain medical conditions that could prevent you from safely participating in EMDR therapy. If you decide to join, you can expect to engage in therapy sessions aimed at helping you manage and reduce your nausea and vomiting symptoms. This trial is not yet recruiting participants, so further information will be available once it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Previously pathologically confirmed diagnosis of cancer
• • Previously treated with systemic cancer therapy
• • Persistent complaints (more than 2 months) of conditioned nausea and/or vomiting
• • Able to understand spoken and written Dutch
• • 18 years or older
• Exclusion Criteria:
• • Ongoing psychiatric treatment
• • EMDR therapy contraindications (dissociative disorders, personality disorders or severe somatic disorders (e.g. cardiac arrhythmias))
• • Complex type 2 trauma
• • Known with recent conditions / non-anti-cancer medication which can elicit nausea (e.g. pregnancy or alcohol abuses)